We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Revolutionizing Surgery with Real-Time Metabolic Profiling

By MedImaging International staff writers
Posted on 27 Jan 2011
Image: The NMR machine will rapidly analyze intact tissue samples from surgery patients (photo courtesy of Imperial College London).
Image: The NMR machine will rapidly analyze intact tissue samples from surgery patients (photo courtesy of Imperial College London).
Surgical metabonomics, the metabolic profiling of tissue samples, could transform the way surgeons make decisions in the operating theatre.

Researchers at the Imperial College London (ICL; London, United Kingdom) Surgical Metabonomics Laboratory (SML) are using a high-resolution solid-state nuclear magnetic resonance (NMR) spectrometer to analyze intact tissue samples, without preparation. Surgeons will be able to take tissue samples and have them loaded straight into the NMR machine, receiving a readily interpretable readout from the analysis within 20 minutes, which would provide information such as whether the tissues is infected or how good its blood supply is. Surgeons might also use the technology to determine exactly which areas of tissue are cancerous.

"This is a radical change of approach that doesn't just apply to surgery. We want to be able to provide a metabolic map of the entire patient journey. Before surgery, metabonomics could tell the doctor how risky surgery might be for that patient, or how best to prepare him for surgery,” said Prof. Jeremy Nicholson, PhD, a leading researcher in biomolecular medicine and head of the department of surgery and cancer, who will lead the SML together with surgical innovator Prof. Lord Ara Darzi, MD. "After the operation, metabonomics might help the doctor to monitor the patient's recovery and prescribe the most suitable drugs or diet. Ultimately we hope to apply this approach to every area of medicine.”

"People respond differently to the physical trauma of surgery, but currently the tools we have to measure how they respond are very limited,” added Lord Darzi. "Blood tests are slow and they can only measure one chemical component at a time; the doctor simply looks at whether a particular measure has gone up or down. Using NMR, we can simultaneously measure all of the chemicals that the body is producing, and analyze those data to give the surgeon real-time information about the patient's condition, which will help him make decisions.”

The science of metabonomics involves comprehensively measuring the metabolic changes in a person's body, using techniques from analytical chemistry that allow researchers to measure simultaneously all of the chemicals produced by the body's metabolism. With knowledge of which molecules correspond to which conditions in the body, this "metabolic fingerprint” can provide a wealth of information about the state of a person's health. Metabonomics has previously been applied to samples of bodily fluids (such as blood and urine) to look for indicators of disease or of how a person might respond to a particular drug.

Related Links:
Imperial College London


Mobile X-Ray System
K4W
Digital X-Ray Detector Panel
Acuity G4
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
X-ray Diagnostic System
FDX Visionary-A

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.